Why dont these guys just go for an industry sale to a larger pharma company that can pump the product through existing sales channels?
It looks like they are having trouble getting traction in the market.
Are there any competitors who produce the same things?
Ann: AtCor to report profit for H1 FY2013 , page-20
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.47M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 67541 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 23/08/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable